Oxford model shows statin muscle risk is tiny, but online hype fuels fear

A team from Oxford University analyzed the health data of 5.7 million people in England and built a predictive model estimating a patient’s chance of serious muscle disorders while taking statins, concluding that 99.6 % of those deemed eligible by doctors face minimal risk. Published in Lancet Digital Health, the model lets clinicians give personalized risk figures to reassure hesitant patients. Nonetheless, a Pew Research poll shows 4 in 10 adults get health information from social-media influencers, many of whom exploit fear of mainstream medicine to sell supplements and coaching.

The misinformation economy targets successful treatments like statins, vaccines and cancer drugs, and platform-level fact-checking has been rolled back on Meta, X and YouTube. To combat this, the piece highlights emerging consumer tools such as NewsGuard’s HealthGuard browser extension and Crickit.ai’s real-time verification overlay, and urges stricter disclosure rules and public education to spot manipulative narratives.